Cholinergic enhancement of brain activation in mild cognitive impairment during episodic memory encoding

Shannon L. Risacher, Yang Wang, Heather A. Wishart, Laura A. Rabin, Laura A. Flashman, Brenna McDonald, John D. West, Robert B. Santulli, Andrew Saykin

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: To determine the physiological impact of treatment with donepezil (Aricept) on neural circuitry supporting episodic memory encoding in patients with amnestic mild cognitive impairment (MCI) using functional magnetic resonance imaging (fMRI). Methods: Eighteen patients with MCI and 20 age-matched healthy controls (HC) were scanned twice while performing an event-related verbal episodic encoding task. MCI participants were scanned before treatment and after approximately 3 months on donepezil; HC were untreated but rescanned at the same interval. Voxel-level analyses assessed treatment effects on activation profiles in MCI patients relative to retest changes in non-treated HC. Changes in task-related connectivity in medial temporal circuitry were also evaluated, as were associations between brain activation, task-related functional connectivity, task performance, and clinical measures of cognition. Results: At baseline, the MCI group showed reduced activation during encoding relative to HC in the right medial temporal lobe (MTL; hippocampal/parahippocampal) and additional regions, as well as attenuated task-related deactivation, relative to rest, in a medial parietal lobe cluster. After treatment, the MCI group showed normalized MTL activation and improved parietal deactivation. These changes were associated with cognitive performance. After treatment, the MCI group also demonstrated increased task-related functional connectivity from the right MTL cluster seed region to a network of other sites including the basal nucleus/caudate and bilateral frontal lobes. Increased functional connectivity was associated with improved task performance. Conclusion: Pharmacologic enhancement of cholinergic function in amnestic MCI is associated with changes in brain activation and functional connectivity during episodic memory processing which are in turn related to increased cognitive performance. fMRI is a promising biomarker for assessing treatment related changes in brain function.

Original languageEnglish
Article numberArticle 105
JournalFrontiers in Psychiatry
Volume4
Issue numberSEP
DOIs
StatePublished - 2013

Fingerprint

Episodic Memory
Cholinergic Agents
Brain
Task Performance and Analysis
Therapeutics
Magnetic Resonance Imaging
Parietal Lobe
Cognitive Dysfunction
Frontal Lobe
Temporal Lobe
Basal Ganglia
Cognition
Seeds
Biomarkers

Keywords

  • Alzheimer's disease
  • Donepezil (Aricept)
  • Episodic encoding
  • Functional magnetic resonance imaging
  • Mild cognitive impairment
  • Task-related functional connectivity

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cholinergic enhancement of brain activation in mild cognitive impairment during episodic memory encoding. / Risacher, Shannon L.; Wang, Yang; Wishart, Heather A.; Rabin, Laura A.; Flashman, Laura A.; McDonald, Brenna; West, John D.; Santulli, Robert B.; Saykin, Andrew.

In: Frontiers in Psychiatry, Vol. 4, No. SEP, Article 105, 2013.

Research output: Contribution to journalArticle

Risacher, Shannon L. ; Wang, Yang ; Wishart, Heather A. ; Rabin, Laura A. ; Flashman, Laura A. ; McDonald, Brenna ; West, John D. ; Santulli, Robert B. ; Saykin, Andrew. / Cholinergic enhancement of brain activation in mild cognitive impairment during episodic memory encoding. In: Frontiers in Psychiatry. 2013 ; Vol. 4, No. SEP.
@article{0f5e725b53f94b4baffa3b03ac21bede,
title = "Cholinergic enhancement of brain activation in mild cognitive impairment during episodic memory encoding",
abstract = "Objective: To determine the physiological impact of treatment with donepezil (Aricept) on neural circuitry supporting episodic memory encoding in patients with amnestic mild cognitive impairment (MCI) using functional magnetic resonance imaging (fMRI). Methods: Eighteen patients with MCI and 20 age-matched healthy controls (HC) were scanned twice while performing an event-related verbal episodic encoding task. MCI participants were scanned before treatment and after approximately 3 months on donepezil; HC were untreated but rescanned at the same interval. Voxel-level analyses assessed treatment effects on activation profiles in MCI patients relative to retest changes in non-treated HC. Changes in task-related connectivity in medial temporal circuitry were also evaluated, as were associations between brain activation, task-related functional connectivity, task performance, and clinical measures of cognition. Results: At baseline, the MCI group showed reduced activation during encoding relative to HC in the right medial temporal lobe (MTL; hippocampal/parahippocampal) and additional regions, as well as attenuated task-related deactivation, relative to rest, in a medial parietal lobe cluster. After treatment, the MCI group showed normalized MTL activation and improved parietal deactivation. These changes were associated with cognitive performance. After treatment, the MCI group also demonstrated increased task-related functional connectivity from the right MTL cluster seed region to a network of other sites including the basal nucleus/caudate and bilateral frontal lobes. Increased functional connectivity was associated with improved task performance. Conclusion: Pharmacologic enhancement of cholinergic function in amnestic MCI is associated with changes in brain activation and functional connectivity during episodic memory processing which are in turn related to increased cognitive performance. fMRI is a promising biomarker for assessing treatment related changes in brain function.",
keywords = "Alzheimer's disease, Donepezil (Aricept), Episodic encoding, Functional magnetic resonance imaging, Mild cognitive impairment, Task-related functional connectivity",
author = "Risacher, {Shannon L.} and Yang Wang and Wishart, {Heather A.} and Rabin, {Laura A.} and Flashman, {Laura A.} and Brenna McDonald and West, {John D.} and Santulli, {Robert B.} and Andrew Saykin",
year = "2013",
doi = "10.3389/fpsyt.2013.00105",
language = "English",
volume = "4",
journal = "Frontiers in Psychiatry",
issn = "1664-0640",
publisher = "Frontiers Research Foundation",
number = "SEP",

}

TY - JOUR

T1 - Cholinergic enhancement of brain activation in mild cognitive impairment during episodic memory encoding

AU - Risacher, Shannon L.

AU - Wang, Yang

AU - Wishart, Heather A.

AU - Rabin, Laura A.

AU - Flashman, Laura A.

AU - McDonald, Brenna

AU - West, John D.

AU - Santulli, Robert B.

AU - Saykin, Andrew

PY - 2013

Y1 - 2013

N2 - Objective: To determine the physiological impact of treatment with donepezil (Aricept) on neural circuitry supporting episodic memory encoding in patients with amnestic mild cognitive impairment (MCI) using functional magnetic resonance imaging (fMRI). Methods: Eighteen patients with MCI and 20 age-matched healthy controls (HC) were scanned twice while performing an event-related verbal episodic encoding task. MCI participants were scanned before treatment and after approximately 3 months on donepezil; HC were untreated but rescanned at the same interval. Voxel-level analyses assessed treatment effects on activation profiles in MCI patients relative to retest changes in non-treated HC. Changes in task-related connectivity in medial temporal circuitry were also evaluated, as were associations between brain activation, task-related functional connectivity, task performance, and clinical measures of cognition. Results: At baseline, the MCI group showed reduced activation during encoding relative to HC in the right medial temporal lobe (MTL; hippocampal/parahippocampal) and additional regions, as well as attenuated task-related deactivation, relative to rest, in a medial parietal lobe cluster. After treatment, the MCI group showed normalized MTL activation and improved parietal deactivation. These changes were associated with cognitive performance. After treatment, the MCI group also demonstrated increased task-related functional connectivity from the right MTL cluster seed region to a network of other sites including the basal nucleus/caudate and bilateral frontal lobes. Increased functional connectivity was associated with improved task performance. Conclusion: Pharmacologic enhancement of cholinergic function in amnestic MCI is associated with changes in brain activation and functional connectivity during episodic memory processing which are in turn related to increased cognitive performance. fMRI is a promising biomarker for assessing treatment related changes in brain function.

AB - Objective: To determine the physiological impact of treatment with donepezil (Aricept) on neural circuitry supporting episodic memory encoding in patients with amnestic mild cognitive impairment (MCI) using functional magnetic resonance imaging (fMRI). Methods: Eighteen patients with MCI and 20 age-matched healthy controls (HC) were scanned twice while performing an event-related verbal episodic encoding task. MCI participants were scanned before treatment and after approximately 3 months on donepezil; HC were untreated but rescanned at the same interval. Voxel-level analyses assessed treatment effects on activation profiles in MCI patients relative to retest changes in non-treated HC. Changes in task-related connectivity in medial temporal circuitry were also evaluated, as were associations between brain activation, task-related functional connectivity, task performance, and clinical measures of cognition. Results: At baseline, the MCI group showed reduced activation during encoding relative to HC in the right medial temporal lobe (MTL; hippocampal/parahippocampal) and additional regions, as well as attenuated task-related deactivation, relative to rest, in a medial parietal lobe cluster. After treatment, the MCI group showed normalized MTL activation and improved parietal deactivation. These changes were associated with cognitive performance. After treatment, the MCI group also demonstrated increased task-related functional connectivity from the right MTL cluster seed region to a network of other sites including the basal nucleus/caudate and bilateral frontal lobes. Increased functional connectivity was associated with improved task performance. Conclusion: Pharmacologic enhancement of cholinergic function in amnestic MCI is associated with changes in brain activation and functional connectivity during episodic memory processing which are in turn related to increased cognitive performance. fMRI is a promising biomarker for assessing treatment related changes in brain function.

KW - Alzheimer's disease

KW - Donepezil (Aricept)

KW - Episodic encoding

KW - Functional magnetic resonance imaging

KW - Mild cognitive impairment

KW - Task-related functional connectivity

UR - http://www.scopus.com/inward/record.url?scp=84885367864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885367864&partnerID=8YFLogxK

U2 - 10.3389/fpsyt.2013.00105

DO - 10.3389/fpsyt.2013.00105

M3 - Article

VL - 4

JO - Frontiers in Psychiatry

JF - Frontiers in Psychiatry

SN - 1664-0640

IS - SEP

M1 - Article 105

ER -